menu
    • menu

    Company profile for Acrivon Therapeutics

    NEW Drugs in Dev: 3
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Acrivon Therapeutics is a precision oncology therapeutics company uniquely enabled by a differentiated proteomics-based patient selection platform. Our method is widely applicable across drug classes and modalities. We specifically apply our approach to challenging oncology drug targets causally implicated in the vast majority of cancers, particularly those without simple single gene driver mutations or synthetic lethal contex...
    Acrivon Therapeutics is a precision oncology therapeutics company uniquely enabled by a differentiated proteomics-based patient selection platform. Our method is widely applicable across drug classes and modalities. We specifically apply our approach to challenging oncology drug targets causally implicated in the vast majority of cancers, particularly those without simple single gene driver mutations or synthetic lethal contexts. Leveraging our unique patient selection platform, Acrivon Therapeutics aims to rapidly progress in-licensed clinical-stage assets and a pipeline of internally developed programs

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Acrivon TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Watertown, MA, USA 480 Arsenal Way Suite 100 Watertown, MA 02472
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://acrivon.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/acrivon/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Acrivon to Announce Update for ACR-368, Initial Data on ACR-2316
    Acrivon to Announce Update for ACR-368, Initial Data on ACR-2316

    17 Dec 2025

    // PRESS RELEASE

    https://ir.acrivon.com/news-releases/news-release-details/acrivon-therapeutics-announce-clinical-update-its-ongoing-phase

    PRESS RELEASE
    17 Dec 2025
    Share Share
    Acrivon Therapeutics Reports Third Quarter 2025 Financial Results
    Acrivon Therapeutics Reports Third Quarter 2025 Financial Results

    13 Nov 2025

    // PRESS RELEASE

    https://ir.acrivon.com/news-releases/news-release-details/acrivon-therapeutics-reports-third-quarter-2025-financial

    PRESS RELEASE
    13 Nov 2025
    Share Share
    Acrivon stops testing Lilly castoff for ovarian, bladder cancer
    Acrivon stops testing Lilly castoff for ovarian, bladder cancer

    26 Mar 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/acrivon-stops-developing-lilly-castoff-ovarian-bladder-cancer-focus-endometrial

    FIERCE BIOTECH
    26 Mar 2025
    Share Share
    Acrivon Initial Positive Data for ACR-368, Pipeline Progress
    Acrivon Initial Positive Data for ACR-368, Pipeline Progress

    24 Apr 2024

    // PRESS RELEASE

    https://ir.acrivon.com/news-releases/news-release-details/acrivon-therapeutics-reports-initial-positive-clinical-data-acr

    PRESS RELEASE
    24 Apr 2024
    Share Share
    Acrivon R&D Event Highlights ACR-368, ACR-2316, AP3 Platform
    Acrivon R&D Event Highlights ACR-368, ACR-2316, AP3 Platform

    16 Apr 2024

    // PRESS RELEASE

    https://ir.acrivon.com/news-releases/news-release-details/acrivon-therapeutics-host-corporate-rd-event-highlighting-ap3

    PRESS RELEASE
    16 Apr 2024
    Share Share
    Acrivon AACR Data on AP3 for ACR-2316, ACR-368 Resistance
    Acrivon AACR Data on AP3 for ACR-2316, ACR-368 Resistance

    10 Apr 2024

    // PRESS RELEASE

    https://ir.acrivon.com/news-releases/news-release-details/acrivon-therapeutics-presents-data-aacr-annual-meeting

    PRESS RELEASE
    10 Apr 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search